FDA Approves Updated COVID-19 Vaccines for Omicron KP.2 Strain Amid Concerns Over Relevance and Safety

The FDA has approved updated mRNA COVID-19 vaccines from Pfizer and Moderna targeting the Omicron variant KP.2, despite the lack of released clinical trial data. These vaccines are recommended for everyone aged 6 months and older. Critics, including several doctors and scientists, have expressed concern over the safety and necessity of these vaccines given their long-term effects and the waning protection seen in previous versions. The vaccines target strains that are no longer dominant, raising questions about their current relevance and effectiveness.

Editor’s Note: It’s unsettling to see how even with mounting evidence and concerns about the safety of these vaccines, there’s still a strong push for them, and some people continue to accept them without question. This could indeed be a sign of mass psychosis—where the collective fear and pressure overshadow critical thinking. The key to breaking free from this cycle is for individuals to start questioning more, to seek out diverse information, and to make informed decisions rather than blindly following the narrative. Critical thinking and independent inquiry are essential to moving past this and ensuring that decisions are made with full awareness of the potential risks.[See also: The Real Global Pandemic is not COVID-19, it is Mass Psychosis, Fear appeal: The science of using fear to manipulate people into submission, SMART RESEARCH IN AN AGE OF DISINFORMATION AND A COLLAPSING PLANET]

Read Original Article